Security National Trust’s Abiomed Inc ABMD Stock Holding History

Security National Trust’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-400	Closed	-$104K	–	370
2019 Q2	$104K	Hold	400	–	–	0.03%	209
2019 Q1	$114K	Hold	400	–	–	0.04%	195
2018 Q4	$130K	Hold	400	–	–	0.05%	180
2018 Q3	$180K	Hold	400	–	–	0.06%	171
2018 Q2	$164K	Hold	400	–	–	0.05%	171
2018 Q1	$116K	Hold	400	–	–	0.04%	202
2017 Q4	$75K	Hold	400	–	–	0.02%	241
2017 Q3	$67K	Hold	400	–	–	0.02%	249
2017 Q2	$57K	Hold	400	–	–	0.02%	268
2017 Q1	$50K	Hold	400	–	–	0.02%	278
2016 Q4	$45K	Hold	400	–	–	0.02%	286
2016 Q3	$51K	Buy	+400	New	+$47.9K	0.02%	270

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Security National Trust's ABMD Position: Q3 2019 in Review

Security National Trust sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 400 shares — an estimated $104K sold.

Security National Trust first reported a position in ABMD in Q3 2016 and held it in 12 quarters. The position peaked at $180K in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

Security National Trust reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
Security National Trust sold 400 Abiomed Inc shares in Q3 2019, an estimated $104K.
Security National Trust first reported a position in Abiomed Inc in Q3 2016 and held it in 12 quarters.
Security National Trust's Abiomed Inc position peaked at $180K in Q3 2018.
443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Security National Trust's 13F filing for Q3 2019, filed 1 Nov 2019.